Filed 20 Jul 2026
Last verified 14 Oct 2026This page records the company’s public listing process. Figures and dates are shown when verified from the linked sources.
Company overview
Its activities included developing, manufacturing, and marketing these therapeutic platforms. The supplied information describes the company’s prior business activities.
- Company country
- United States
Offering details
Base offering, before overallotment
- Exchange
- Nasdaq Capital Market
- Ticker
- GVTX
- Shares offered
- 3,225,806
- Shares after offering
- 34,895,554
- New shares
- 3,225,806
- Existing shares sold
- 0